Yuzheng Zhou

857 total citations · 1 hit paper
25 papers, 321 citations indexed

About

Yuzheng Zhou is a scholar working on Molecular Biology, Infectious Diseases and Immunology. According to data from OpenAlex, Yuzheng Zhou has authored 25 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Infectious Diseases and 6 papers in Immunology. Recurrent topics in Yuzheng Zhou's work include SARS-CoV-2 and COVID-19 Research (6 papers), interferon and immune responses (6 papers) and Advanced Adaptive Filtering Techniques (2 papers). Yuzheng Zhou is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (6 papers), interferon and immune responses (6 papers) and Advanced Adaptive Filtering Techniques (2 papers). Yuzheng Zhou collaborates with scholars based in China, United States and Japan. Yuzheng Zhou's co-authors include Zanxian Xia, Cyrollah Disoma, Shanni Li, Jian Peng, Zijun Dong, Shiqin Li, Aroona Razzaq, Ashuai Du, Zongpeng Chen and Pinjia Liu and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Membrane Science and Molecular Cancer.

In The Last Decade

Yuzheng Zhou

20 papers receiving 318 citations

Hit Papers

M6A-mediated upregulation of circMDK promotes tumorigenes... 2022 2026 2023 2024 2022 40 80 120
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. M6A-mediated upregulation of circMDK promotes tumorigenesis and acts as a nanotherapeutic target in hepatocellular carcinoma
    2022 145 citations Ashuai Du, Shiqin Li et al. Molecular Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuzheng Zhou China 9 222 123 37 37 34 25 321
Cui‐Ling Ding China 9 173 0.8× 141 1.1× 25 0.7× 38 1.0× 21 0.6× 14 316
Ming-Jie Huang China 11 206 0.9× 87 0.7× 27 0.7× 23 0.6× 31 0.9× 18 360
Haiyan Du China 11 234 1.1× 128 1.0× 49 1.3× 35 0.9× 30 0.9× 22 346
Zhengyang Guo China 13 271 1.2× 113 0.9× 44 1.2× 70 1.9× 32 0.9× 26 390
Magnolia Muk‐Lan Lee Hong Kong 8 283 1.3× 88 0.7× 27 0.7× 55 1.5× 27 0.8× 10 362
Kunwar Somesh Vikramdeo United States 12 150 0.7× 66 0.5× 42 1.1× 29 0.8× 30 0.9× 24 272
Dieter Galea United Kingdom 10 329 1.5× 103 0.8× 68 1.8× 40 1.1× 17 0.5× 14 482
Xi Tan Canada 7 162 0.7× 143 1.2× 49 1.3× 33 0.9× 35 1.0× 8 331
Yaqi Gao China 9 198 0.9× 83 0.7× 99 2.7× 49 1.3× 33 1.0× 21 327
Diógenes S. de Lima Brazil 8 175 0.8× 74 0.6× 19 0.5× 59 1.6× 23 0.7× 8 352

Countries citing papers authored by Yuzheng Zhou

Since Specialization
Citations

This map shows the geographic impact of Yuzheng Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuzheng Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuzheng Zhou more than expected).

Fields of papers citing papers by Yuzheng Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuzheng Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuzheng Zhou. The network helps show where Yuzheng Zhou may publish in the future.

Co-authorship network of co-authors of Yuzheng Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Yuzheng Zhou. A scholar is included among the top collaborators of Yuzheng Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuzheng Zhou. Yuzheng Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Yuzheng, Taijie Guo, Xiao Zhang, et al.. (2025). Discovery of SARS-CoV-2 PLpro inhibitors and RIPK1 inhibitors with synergistic antiviral efficacy in a mouse COVID-19 model. Acta Pharmaceutica Sinica B. 16(1). 387–405.
2.
3.
Hojo, Hidehiro, Masaki Nakamura, Hidenari Hirata, et al.. (2025). Clinical Outcomes of Patients Receiving Stereotactic Body Radiotherapy Dose De-escalation for Hepatocellular Carcinoma at the Hepatic Hilum. Anticancer Research. 45(3). 1159–1169.
4.
Zhang, Kun, et al.. (2024). Graph-based minimum error entropy Kalman filtering. Signal Processing. 222. 109535–109535. 3 indexed citations
5.
Zhou, Jian, Yuzheng Zhou, Xiang Gao, et al.. (2024). TRIM6 facilitates SARS‐CoV‐2 proliferation by catalyzing the K29‐typed ubiquitination of NP to enhance the ability to bind viral genomes. Journal of Medical Virology. 96(3). e29531–e29531. 6 indexed citations
6.
Liu, Sixu, Yuzheng Zhou, Yuqing Zhou, et al.. (2024). Discovery of meisoindigo derivatives as noncovalent and orally available Mpro inhibitors: their therapeutic implications in the treatment of COVID-19. European Journal of Medicinal Chemistry. 273. 116498–116498. 3 indexed citations
7.
Zhao, Xiaoran, Liting Hu, Guibo Liu, et al.. (2024). Fibronectin binds integrin α5β1 to regulate macular neovascularization through the Wnt/β-catenin signaling pathway. Experimental Eye Research. 242. 109880–109880. 2 indexed citations
8.
9.
Zhou, Yuzheng, Xiang Gao, Jian Zhou, et al.. (2024). Ciclopirox inhibits SARS-CoV-2 replication by promoting the degradation of the nucleocapsid protein. Acta Pharmaceutica Sinica B. 14(6). 2505–2519. 4 indexed citations
10.
Zhong, Shan, et al.. (2023). Robust adaptive filtering based on M-estimation-based minimum error entropy criterion. Information Sciences. 658. 120026–120026. 11 indexed citations
11.
Razzaq, Aroona, Cyrollah Disoma, Yuzheng Zhou, et al.. (2023). Targeting epidermal growth factor receptor signalling pathway: A promising therapeutic option for COVID‐19. Reviews in Medical Virology. 34(1). e2500–e2500. 3 indexed citations
12.
13.
Hirata, Hidenari, Sadamoto Zenda, Yuzheng Zhou, et al.. (2023). Prognostic impact of EGFR/ALK alterations in leptomeningeal metastasis from lung adenocarcinoma treated with whole-brain radiotherapy. Clinical & Experimental Metastasis. 40(5). 407–413. 1 indexed citations
14.
Disoma, Cyrollah, Yuzheng Zhou, Shanni Li, Jian Peng, & Zanxian Xia. (2022). Wnt/β-catenin signaling in colorectal cancer: Is therapeutic targeting even possible?. Biochimie. 195. 39–53. 49 indexed citations
15.
Du, Ashuai, Shiqin Li, Yuzheng Zhou, et al.. (2022). M6A-mediated upregulation of circMDK promotes tumorigenesis and acts as a nanotherapeutic target in hepatocellular carcinoma. Molecular Cancer. 21(1). 109–109. 145 indexed citations breakdown →
16.
Li, Shiqin, Sijia Li, Cyrollah Disoma, et al.. (2020). SARS‐CoV‐2: Mechanism of infection and emerging technologies for future prospects. Reviews in Medical Virology. 31(2). e2168–e2168. 19 indexed citations
17.
Disoma, Cyrollah, Yuzheng Zhou, Zongpeng Chen, et al.. (2019). Protein interactome of the deamidase phosphoribosylformylglycinamidine synthetase (PFAS) by LC-MS/MS. Biochemical and Biophysical Research Communications. 513(3). 746–752. 14 indexed citations
18.
Chen, Jie, Jun Zhao, Xuan Chen, et al.. (2017). Hyper activation of β‐catenin signalling induced by IKKε inhibition thwarts colorectal cancer cell proliferation. Cell Proliferation. 50(4). 10 indexed citations
19.
Zhou, Yuzheng, Wenbin Zeng, Min Qi, et al.. (2017). Low dose arsenite confers resistance to UV induced apoptosis via p53-MDM2 pathway in ketatinocytes. Oncogenesis. 6(8). e370–e370. 6 indexed citations
20.
Yu, Haiyang, Xiaoqing Zhang, Ren Liu, et al.. (2017). Mcl-1 suppresses abasic site repair following bile acid–induced hepatic cellular DNA damage. Tumor Biology. 39(7). 3726132810–3726132810. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cui‐Ling Ding Breakdown of academic impact, for papers by Ming-Jie Huang Breakdown of academic impact, for papers by Haiyan Du Breakdown of academic impact, for papers by Zhengyang Guo Breakdown of academic impact, for papers by Magnolia Muk‐Lan Lee Breakdown of academic impact, for papers by Kunwar Somesh Vikramdeo Breakdown of academic impact, for papers by Dieter Galea Breakdown of academic impact, for papers by Xi Tan Breakdown of academic impact, for papers by Yaqi Gao Breakdown of academic impact, for papers by Diógenes S. de Lima
Rankless by CCL
2026